Frontiers of Medicine 2021;15(4):621-628

doi:10.1007/s11684-020-0738-0

Prognostic value of the 21-gene recurrence score in ER-positive, HER2-negative, node-positive breast cancer was similar in node-negative diseases: a single-center study of 800 patients.

Jiayi WU 1 ; Weiqi GAO 1 ; Xiaosong CHEN 1 ; Chunxiao FEI 1 ; Lin LIN 1 ; Weiguo CHEN 1 ; Ou HUANG 1 ; Siji ZHU 1 ; Jianrong HE 1 ; Yafen LI 1 ; Li ZHU 1 ; Kunwei SHEN 2

Affiliations

+expand

Keywords

21-gene assay; early breast cancer; prognosis; recurrence score

Country

China

Language

English

Abstract

Multi-gene assays have emerged as crucial tools for risk stratification in early-stage breast cancer. This study aimed to evaluate the prognostic significance of the 21-gene recurrence score (RS) in Chinese patients with pN0-1, estrogen receptor-positive (ER